DEERFIELD MANAGEMENT COMPANY, L.P. Q2 2017 Filing
Filed August 14, 2017
Portfolio Value
$1.9T
Holdings
83
Report Date
Q2 2017
Filing Type
13F-HR
All Holdings (83 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —AVEXIS INC | 2,308,130 | $189.6B | 10.12% | |
| 2 | GILDGILEAD SCIENCES INC | 1,688,515 | $119.5B | 6.37% | Call |
| 3 | —HORIZON PHARMA PLC | 8,998,413 | $106.8B | 5.70% | |
| 4 | —NXSTAGE MEDICAL INC | 3,833,330 | $96.1B | 5.13% | |
| 5 | —HORIZON PHARMA INVT LTD | 74,100,000 | $64.0B | 3.41% | |
| 6 | —MYLAN N V | 1,367,119 | $53.1B | 2.83% | |
| 7 | —MALLINCKRODT PUB LTD CO | 1,178,605 | $52.8B | 2.82% | |
| 8 | MCKMCKESSON CORP | 315,417 | $51.9B | 2.77% | |
| 9 | AERIEURAERIE PHARMACEUTICALS INC | 961,147 | $50.5B | 2.69% | |
| 10 | —ISIS PHARMACEUTICALS INC DEL | 42,200,000 | $44.9B | 2.39% | |
| 11 | —KEMPHARM INC | 75,000,000 | $44.3B | 2.36% | |
| 12 | AVDLAVADEL PHARMACEUTICALS PLC | 3,655,494 | $40.3B | 2.15% | |
| 13 | TRIB 4 04/01/45TRINITY BIOTECH INVT LTD | 48,000,000 | $38.4B | 2.05% | |
| 14 | GKOSGLAUKOS CORP | 894,551 | $37.1B | 1.98% | |
| 15 | —GW PHARMACEUTICALS PLC | 359,983 | $36.1B | 1.92% | |
| 16 | —ENDOLOGIX INC | 40,500,000 | $34.3B | 1.83% | |
| 17 | —INTERSECT ENT INC | 1,189,577 | $33.2B | 1.77% | |
| 18 | —AUDENTES THERAPEUTICS INC | 1,729,268 | $33.1B | 1.76% | |
| 19 | LN5LANNET INC | 1,523,957 | $31.1B | 1.66% | |
| 20 | —NEVRO CORP | 27,600,000 | $29.6B | 1.58% | |
| 21 | EDITEDITAS MEDICINE INC | 1,709,400 | $28.7B | 1.53% | |
| 22 | NVROEURNEVRO CORP | 376,308 | $28.0B | 1.49% | |
| 23 | —DBV TECHNOLOGIES S A | 665,197 | $23.8B | 1.27% | |
| 24 | —PORTOLA PHARMACEUTICALS INC | 419,000 | $23.5B | 1.26% | |
| 25 | BCRXBIOCRYST PHARMACEUTICALS | 3,999,202 | $22.2B | 1.19% | Call |
| 26 | —INTERCEPT PHARMACEUTICALS IN | 22,500,000 | $22.0B | 1.17% | |
| 27 | SELBUSDSELECTA BIOSCIENCES INC | 1,060,000 | $21.1B | 1.12% | |
| 28 | —SYROS PHARMACEUTICALS INC | 1,268,945 | $20.4B | 1.09% | |
| 29 | —LOXO ONCOLOGY INC | 251,167 | $20.1B | 1.07% | |
| 30 | —AETNA INC NEW | 130,000 | $19.7B | 1.05% | |
| 31 | PDCOEURPATTERSON COMPANIES INC | 393,262 | $18.5B | 0.98% | |
| 32 | DC4DEXCOM INC | 247,841 | $18.1B | 0.97% | |
| 33 | LAB 2.75 02/01/34FLUIDIGM CORP DEL | 27,715,000 | $17.2B | 0.92% | |
| 34 | —OXFORD IMMUNOTEC GLOBAL PLC | 945,710 | $15.9B | 0.85% | |
| 35 | —ADVANCED ACCELERATOR APPLIC | 392,904 | $15.3B | 0.82% | |
| 36 | GLPGGALAPAGOS NV | 187,501 | $14.3B | 0.77% | |
| 37 | ELVANTHEM INC | 75,182 | $14.1B | 0.75% | |
| 38 | WVEWAVE LIFE SCIENCES LTD | 746,841 | $13.9B | 0.74% | |
| 39 | —AAC HLDGS INC | 1,975,347 | $13.7B | 0.73% | |
| 40 | —AEGERION PHARMACEUTICALS INC | 16,600,000 | $13.5B | 0.72% | |
| 41 | SCTLRECRO PHARMA INC | 1,901,685 | $13.4B | 0.71% | |
| 42 | ANABANAPTYSBIO INC | 552,859 | $13.2B | 0.71% | |
| 43 | EHTHEHEALTH INC | 690,348 | $13.0B | 0.69% | |
| 44 | XNCRXENCOR INC | 562,236 | $11.9B | 0.63% | |
| 45 | CTMXCYTOMX THERAPEUTICS INC | 756,822 | $11.7B | 0.63% | |
| 46 | ASNDASCENDIS PHARMA A S | 419,453 | $11.6B | 0.62% | |
| 47 | ARDXARDELYX INC | 2,279,780 | $11.6B | 0.62% | |
| 48 | AXGNAXOGEN INC | 674,428 | $11.3B | 0.60% | |
| 49 | ARGXARGENX SE | 509,022 | $10.8B | 0.58% | |
| 50 | —NEOS THERAPEUTICS INC | 1,459,195 | $10.7B | 0.57% | |
| 51 | MOHMOLINA HEALTHCARE INC | 151,665 | $10.5B | 0.56% | |
| 52 | 2L9BLUEPRINT MEDICINES CORP | 203,000 | $10.3B | 0.55% | |
| 53 | ACRSACLARIS THERAPEUTICS INC | 375,000 | $10.2B | 0.54% | |
| 54 | —EPIZYME INC | 662,369 | $10.0B | 0.53% | |
| 55 | —ALLSCRIPTS HEALTHCARE SOLUTN | 9,671,000 | $9.8B | 0.52% | |
| 56 | GBYSANGAMO THERAPEUTICS INC | 1,094,305 | $9.6B | 0.51% | |
| 57 | CNCCENTENE CORP DEL | 119,000 | $9.5B | 0.51% | |
| 58 | PBYIPUMA BIOTECHNOLOGY INC | 104,000 | $9.1B | 0.48% | Put |
| 59 | —STEADYMED LTD | 1,441,913 | $9.1B | 0.48% | |
| 60 | —NIVALIS THERAPEUTICS INC | 3,732,412 | $9.0B | 0.48% | |
| 61 | —INVUITY INC | 1,177,229 | $8.5B | 0.46% | |
| 62 | SEMSELECT MED HLDGS CORP | 504,632 | $7.7B | 0.41% | |
| 63 | ARNAEURARENA PHARMACEUTICALS INC | 416,729 | $7.0B | 0.37% | |
| 64 | —ALIMERA SCIENCES INC | 4,769,551 | $6.6B | 0.35% | |
| 65 | —AXOVANT SCIENCES LTD | 239,180 | $5.5B | 0.30% | |
| 66 | —BIOHAVEN PHARMACTL HLDG CO L | 216,761 | $5.4B | 0.29% | |
| 67 | —MYOVANT SCIENCES LTD | 400,685 | $4.7B | 0.25% | |
| 68 | —SIERRA ONCOLOGY INC | 3,495,734 | $4.1B | 0.22% | |
| 69 | MNKDMANNKIND CORP | 2,702,403 | $3.8B | 0.20% | |
| 70 | —FOAMIX PHARMACEUTICALS LTD | 817,435 | $3.8B | 0.20% | |
| 71 | —AKARI THERAPEUTICS PLC | 818,158 | $3.8B | 0.20% | |
| 72 | —MYOKARDIA INC | 279,752 | $3.7B | 0.20% | |
| 73 | —BIOSCRIP INC | 1,327,966 | $3.6B | 0.19% | |
| 74 | —AGILE THERAPEUTICS INC | 955,109 | $3.6B | 0.19% | |
| 75 | JNCEEURJOUNCE THERAPEUTICS INC | 247,872 | $3.5B | 0.19% | |
| 76 | —KEMPHARM INC | 704,612 | $2.8B | 0.15% | |
| 77 | —ARALEZ PHARMACEUTICALS INC | 1,644,583 | $2.2B | 0.12% | |
| 78 | —PROTEON THERAPEUTICS INC | 1,224,899 | $1.9B | 0.10% | |
| 79 | —OBALON THERAPEUTICS INC | 183,086 | $1.8B | 0.10% | |
| 80 | —RA PHARMACEUTICALS INC | 82,593 | $1.5B | 0.08% | |
| 81 | VYGRVOYAGER THERAPEUTICS INC | 117,647 | $1.1B | 0.06% | |
| 82 | —ESSA PHARMA INC | 1,416,230 | $779.0M | 0.04% | |
| 83 | —PROTEOSTASIS THERAPEUTICS IN | 17,251 | $81.0M | 0.00% |